CLSA maintains sell on Biocon, target price Rs 220

The company’s third quarter result was operationally in line with estimates but a higher tax rate led to a 10% miss on reported profit.

from Stocks-Markets-Economic Times https://ift.tt/3aOASGi

Comments

Popular posts from this blog